1887

oa Central African Journal of Medicine - Therapeutic Review: Tuberculosis

Volume 37, Issue 8
  • ISSN : 0008-9176

 

Abstract

Tuberculosis (TB) is increasing in Zimbabwe and other countries in Africa and world-wide. TB treatment and control face new difficulties including the impact of the HIV epidemic and drug resistance. There is now abundant evidence that six-month regimens are highly effective and, by improving compliance, can improve results and the cost-effectiveness of therapy. Intermittent therapy reduces drug costs and allows for the possibility of complete supervision. The optimal management of the HIV-infected TB patient has not yet been established but an increased rate of drug reactions suggests that standard treatment should be reassessed.

Loading full text...

Full text loading...

Loading

Article metrics loading...

/content/CAJM/37/8/AJA00089176_247
1991-08-01
2019-08-24

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error